Found: 59
Select item for more details and to access through your institution.
Phase Ib study evaluating safety and clinical activity of the anti-HER3 antibody lumretuzumab combined with the anti-HER2 antibody pertuzumab and paclitaxel in HER3-positive, HER2-low metastatic breast cancer.
- Published in:
- Investigational New Drugs, 2018, v. 36, n. 5, p. 848, doi. 10.1007/s10637-018-0562-4
- By:
- Publication type:
- Article
Longitudinal investigation of cognitive deficits in breast cancer patients and their gray matter correlates: impact of education level.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Impact of web application support versus standard management on adherence with adjuvant hormone therapy in patients treated for breast cancer: the WEBAPPAC study.
- Published in:
- BMC Cancer, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12885-023-11242-1
- By:
- Publication type:
- Article
Cognition and Return to Work Status 2 Years After Breast Cancer Diagnosis.
- Published in:
- JAMA Network Open, 2024, v. 7, n. 8, p. e2427576, doi. 10.1001/jamanetworkopen.2024.27576
- By:
- Publication type:
- Article
Dynamic Projection of Medication Nonpersistence and Nonadherence Among Patients With Early Breast Cancer.
- Published in:
- JAMA Network Open, 2024, v. 7, n. 5, p. e2411909, doi. 10.1001/jamanetworkopen.2024.11909
- By:
- Publication type:
- Article
Chemotherapy-Related Amenorrhea and Quality of Life Among Premenopausal Women With Breast Cancer.
- Published in:
- JAMA Network Open, 2023, v. 6, n. 11, p. e2343910, doi. 10.1001/jamanetworkopen.2023.43910
- By:
- Publication type:
- Article
Hormonal Receptor Immunochemistry Heterogeneity and <sup>18</sup>F-FDG Metabolic Heterogeneity: Preliminary Results of Their Relationship and Prognostic Value in Luminal Non-Metastatic Breast Cancers.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. N.PAG, doi. 10.3389/fonc.2020.599050
- By:
- Publication type:
- Article
PELICAN-IPC 2015-016/Oncodistinct-003: A Prospective, Multicenter, Open-Label, Randomized, Non-Comparative, Phase II Study of Pembrolizumab in Combination With Neo Adjuvant EC-Paclitaxel Regimen in HER2-Negative Inflammatory Breast Cancer.
- Published in:
- Frontiers in Oncology, 2020, v. 11, p. N.PAG, doi. 10.3389/fonc.2020.575978
- By:
- Publication type:
- Article
HELENA: HER2-Low as a prEdictive factor of response to Neoadjuvant chemotherapy in eArly breast cancer.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Clinicopathological characteristics and prognosis of breast cancer patients with isolated central nervous system metastases in the multicentre ESME database.
- Published in:
- Therapeutic Advances in Medical Oncology, 2022, p. 1, doi. 10.1177/17588359221077082
- By:
- Publication type:
- Article
Real-world evidence of the management and prognosis of young women (⩽40 years) with de novo metastatic breast cancer.
- Published in:
- Therapeutic Advances in Medical Oncology, 2022, p. 1, doi. 10.1177/17588359211070362
- By:
- Publication type:
- Article
Outcomes of patients with HER2-negative metastatic breast cancer after platinum- and non-platinum-based first-line chemotherapy among patients with and without pathogenic germline BRCA1/2 mutations.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Multicenter evaluation of breast cancer patients' satisfaction and experience with oncology telemedicine visits during the COVID-19 pandemic.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Impact of breast cancer on prospective memory functioning assessed by virtual reality and influence of sleep quality and hormonal therapy: PROSOM-K study.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Mutational Profile of Metastatic Breast Cancers: A Retrospective Analysis.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Neoadjuvant anthracycline-based (5-FEC) or anthracycline-free (docetaxel/carboplatin) chemotherapy plus trastuzumab and pertuzmab in HER2 + BC patients according to their TOP2A: a multicentre, open-label, non-randomized phase II trial.
- Published in:
- Breast Cancer Research & Treatment, 2024, v. 205, n. 2, p. 267, doi. 10.1007/s10549-024-07285-y
- By:
- Publication type:
- Article
Pattern and risk factors of isolated local relapse among women with hormone receptor-positive and HER2-negative breast cancer and lymph node involvement: 10-year follow-up analysis of the PACS 01 and PACS 04 trials.
- Published in:
- Breast Cancer Research & Treatment, 2023, v. 199, n. 2, p. 371, doi. 10.1007/s10549-023-06912-4
- By:
- Publication type:
- Article
Progression-free survival on endocrine therapy, before or after chemotherapy, in hormone receptor-positive HER2-negative metastatic breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2022, v. 191, n. 1, p. 191, doi. 10.1007/s10549-021-06382-6
- By:
- Publication type:
- Article
A randomized, placebo-controlled phase 2 study of paclitaxel in combination with reparixin compared to paclitaxel alone as front-line therapy for metastatic triple-negative breast cancer (fRida).
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 190, n. 2, p. 265, doi. 10.1007/s10549-021-06367-5
- By:
- Publication type:
- Article
Association between FGFR1 copy numbers, MAP3K1 mutations, and survival in axillary node-positive, hormone receptor-positive, and HER2-negative early breast cancer in the PACS04 and METABRIC studies.
- Published in:
- Breast Cancer Research & Treatment, 2020, v. 179, n. 2, p. 387, doi. 10.1007/s10549-019-05462-y
- By:
- Publication type:
- Article
Oral etoposide in heavily pre-treated metastatic breast cancer: results from the ESME cohort and comparison with other chemotherapy regimens.
- Published in:
- Breast Cancer Research & Treatment, 2019, v. 173, n. 2, p. 397, doi. 10.1007/s10549-018-5017-2
- By:
- Publication type:
- Article
Efficacy and safety of trastuzumab emtansine (T-DM1) in patients with HER2-positive breast cancer with brain metastases.
- Published in:
- Breast Cancer Research & Treatment, 2016, v. 157, n. 2, p. 307, doi. 10.1007/s10549-016-3828-6
- By:
- Publication type:
- Article
Adjuvant endocrine therapy uptake, toxicity, quality of life, and prediction of early discontinuation.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2023, v. 115, n. 9, p. 1099, doi. 10.1093/jnci/djad109
- By:
- Publication type:
- Article
Cognitive change in breast cancer patients up to 2 years after diagnosis.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2023, v. 115, n. 3, p. 322, doi. 10.1093/jnci/djac240
- By:
- Publication type:
- Article
Baseline lymphopenia as prognostic factor in patients with metastatic breast cancer treated with palbociclib.
- Published in:
- Oncology Letters, 2022, v. 23, n. 1, p. N.PAG
- By:
- Publication type:
- Article
Risk of early progression according to circulating ESR1 mutation, CA-15.3 and cfDNA increases under first-line anti-aromatase treatment in metastatic breast cancer.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Circulating tumor DNA predicts efficacy of a dual AKT/p70S6K inhibitor (LY2780301) plus paclitaxel in metastatic breast cancer: plasma analysis of the TAKTIC phase IB/II study.
- Published in:
- Molecular Oncology, 2022, v. 16, n. 10, p. 2057, doi. 10.1002/1878-0261.13188
- By:
- Publication type:
- Article
Association between progression-free survival and overall survival in women receiving first-line treatment for metastatic breast cancer: evidence from the ESME real-world database.
- Published in:
- BMC Medicine, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12916-023-02754-5
- By:
- Publication type:
- Article
Association between progression-free survival and overall survival in women receiving first-line treatment for metastatic breast cancer: evidence from the ESME real-world database.
- Published in:
- BMC Medicine, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12916-023-02754-5
- By:
- Publication type:
- Article
Cognitive Changes After Adjuvant Treatment in Older Adults with Early‐Stage Breast Cancer.
- Published in:
- Oncologist, 2019, v. 24, n. 1, p. 62, doi. 10.1634/theoncologist.2017-0570
- By:
- Publication type:
- Article
Decline in Cognitive Function in Older Adults With Early-Stage Breast Cancer After Adjuvant Treatment.
- Published in:
- Oncologist, 2016, v. 21, n. 11, p. 1337, doi. 10.1634/theoncologist.2016-0014
- By:
- Publication type:
- Article
Extended Benefit from Sequential Administration of Docetaxel after Standard Fluorouracil, Epirubicin, and Cyclophosphamide Regimen for Node-Positive Breast Cancer: The 8-Year Follow-Up Results of the UNICANCER-PACS01 Trial.
- Published in:
- Oncologist, 2012, v. 17, n. 7, p. 900, doi. 10.1634/theoncologist.2011-0442
- By:
- Publication type:
- Article
Pretreatment neutrophil to lymphocyte ratio as prognostic factor in metastatic breast cancer treated with cyclin dependent kinase 4/6 inhibitors.
- Published in:
- Frontiers in Oncology, 2023, v. 13, p. 1, doi. 10.3389/fonc.2022.1105587
- By:
- Publication type:
- Article
Characteristics and outcome of breast cancer-related microangiopathic haemolytic anaemia: a multicentre study.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Baseline quality of life and chemotherapy toxicities in patients with early breast cancer.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 7, p. 1085, doi. 10.1002/cncr.34643
- By:
- Publication type:
- Article
Cognitive rehabilitation program to improve cognition of cancer patients treated with chemotherapy: A 3‐arm randomized trial.
- Published in:
- Cancer (0008543X), 2020, v. 126, n. 24, p. 5328, doi. 10.1002/cncr.33186
- By:
- Publication type:
- Article
Real-life prognosis of 5041 bone-only metastatic breast cancer patients in the multicenter national observational ESME program.
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/1758835920987657
- By:
- Publication type:
- Article
Real-life prognosis of 5041 bone-only metastatic breast cancer patients in the multicenter national observational ESME program.
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/1758835920987657
- By:
- Publication type:
- Article
Management and outcome of male metastatic breast cancer in the national multicenter observational research program Epidemiological Strategy and Medical Economics (ESME).
- Published in:
- Therapeutic Advances in Medical Oncology, 2020, p. 1, doi. 10.1177/1758835920980548
- By:
- Publication type:
- Article
Constitutional variants are not associated with HER2-positive breast cancer: results from the SIGNAL/PHARE clinical cohort.
- Published in:
- NPJ Breast Cancer, 2017, v. 3, n. 1, p. N.PAG, doi. 10.1038/s41523-017-0005-y
- By:
- Publication type:
- Article
Sustainable return to work among breast cancer survivors.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 18, p. 19091, doi. 10.1002/cam4.6467
- By:
- Publication type:
- Article
Self‐referential processes and resting‐state connectivity in breast cancer patients before and 1 year after chemotherapy.
- Published in:
- European Journal of Neuroscience, 2022, v. 55, n. 2, p. 624, doi. 10.1111/ejn.15587
- By:
- Publication type:
- Article
Treatment patterns, clinical outcomes and health care costs associated with her2-positive breast cancer with central nervous system metastases: a French multicentre observational study.
- Published in:
- BMC Health Services Research, 2013, v. 13, n. 1, p. 1, doi. 10.1186/1472-6963-13-456
- By:
- Publication type:
- Article
Treatment patterns, clinical outcomes and health care costs associated with HER2-positive breast cancer with central nervous system metastases: a French multicentre observational study.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Staging the axilla in breast cancer patients with F-FDG PET: how small are the metastases that we can detect with new generation clinical PET systems?
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2014, v. 41, n. 6, p. 1103, doi. 10.1007/s00259-014-2689-7
- By:
- Publication type:
- Article
Implications of reconstruction protocol for histo-biological characterisation of breast cancers using FDG-PET radiomics.
- Published in:
- EJNMMI Research, 2018, v. 8, n. 1, p. 1, doi. 10.1186/s13550-018-0466-5
- By:
- Publication type:
- Article
Long-Term Results with Everolimus in Advanced Hormone Receptor Positive Breast Cancer in a Multicenter National Real-World Observational Study.
- Published in:
- Cancers, 2023, v. 15, n. 4, p. 1191, doi. 10.3390/cancers15041191
- By:
- Publication type:
- Article
Different Prognostic Values of Tumour and Nodal Response to Neoadjuvant Chemotherapy Depending on Subtypes of Inflammatory Breast Cancer, a 317 Patient-Study.
- Published in:
- Cancers, 2022, v. 14, n. 16, p. 3928, doi. 10.3390/cancers14163928
- By:
- Publication type:
- Article
Toxicity of locoregional radiotherapy in combination with bevacizumab in patients with non-metastatic breast cancer (TOLERAB): Final long-term evaluation.
- Published in:
- PLoS ONE, 2019, v. 14, n. 8, p. 1, doi. 10.1371/journal.pone.0221816
- By:
- Publication type:
- Article
Survival outcomes of metastatic breast cancer patients by germline BRCA1/2 status in a large multicenter real‐world database.
- Published in:
- International Journal of Cancer, 2023, v. 152, n. 5, p. 921, doi. 10.1002/ijc.34304
- By:
- Publication type:
- Article